HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Tonix Pharmaceuticals Holding Corp. (TNXP)
0.5985  -0.0096  (-1.58%) 07-03 15:50
Open: 0.605 High: 0.6072
Pre.close: 0.6081 Low: 0.59
Volume: 4,854,142 Ave vol: 7,614,947
52w High: 13 52w Low: 0.39
MA(50): 0.653 MA(200): 0.876
EPS: -4.516 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.tonixpharma.com
Market Cap (M): 33
Shares Out (M): 55
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, licensing, acquiring, and developing drugs and biologics to treat and prevent human disease and alleviate suffering in the United States. It is developing TNX-102 SL, a tablet containing cyclobenzaprine that is Phase III clinical trial for the treatment of fibromyalgia; and that is in Phase III clinical trial for the treatment of posttraumatic stress disorder, as well as TNX-102 SL for the treatment of agitation in Alzheimer's disease and alcohol use disorder.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bearish
Target 1: 0.80 Target 2: 0.89
Resist 1: 0.69 Resist 2: 0.76
Support 1: 0.57 Support 2: 0.47
Company key metrics
Revenue per Share: 0
Net Income per Share: -17.791
Cash per Share: 6.9932
Book Value per Share: 5.8543
Price to Sales: 0
Price to Book Value: 0.2255
Earnings Yield: -13.478
Dividend Yield: -1.1652
Debt to Equity: 0.5459
Debt to Assets: 0.3531
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Fri, 26 Jun 2020
Tonix Pharmaceuticals Holding Corp. (TNXP) return on Assets touches -140.02: These Shares are Poised for Major Movement - News Daemon

Mon, 22 Jun 2020
Tonix Pharmaceuticals Announces Results from Preclinical Study of TNX-1700 Presented in a Poster at AACR Virtual Annual Meeting 2020 - GlobeNewswire

Thu, 25 Jun 2020
Tonix Pharmaceuticals Holding Corp. (TNXP) and the Battle of Fundamental vs. Technical - The News Heater

Fri, 26 Jun 2020
Tonix Pharmaceuticals Holding Corp. (TNXP) Chart Is Flashing Mixed Signals - The News Heater

Wed, 17 Jun 2020
Here's How One Should Trade Tonix Pharmaceuticals Holding Corp. (TNXP) Now - The News Heater

Wed, 24 Jun 2020
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Expands Partnership On Development of TNX-1800 Release Preclinical Results of TNX1700 Study - BP Journal

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.